Avidity Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
LA JOLLA, Calif., Dec. 22, 2020 /PRNewswire/ --Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Sarah Boyce, President and Chief Executive Officer, is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14th, 2021 at 12:40pm PST. The conference is being held in a virtual format.
A live webcast of the presentation will be available on the Company's website at www.aviditybiosciences.com in the Investor Resources section. A replay of the presentation will be archived on the Company's website for 30 days.
About Avidity Biosciences
Avidity is headquartered in La Jolla, CA. For more information about our science, pipeline and people, please visit www.aviditybiosciences.com and engage with us on LinkedIn.
Media and Investors:
View original content to download multimedia:http://www.prnewswire.com/news-releases/avidity-biosciences-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301196348.html
SOURCE Avidity Biosciences, Inc.
Company Codes: NASDAQ-NMS:RNA